COMMUNIQUÉS West-GlobeNewswire

USAHS Brings Healthcare Professionals Together to Spark Action on Workplace Mental Health
15/09/2026
The event will offer practical strategies to healthcare professionals and students in rehabilitative health sciences programs. ST. AUGUSTINE, Fla., Sept. 15, 2026 (GLOBE NEWSWIRE) -- The University of St. Augustine for [...]
FemPulse Clinical Data to be Presented at ICS on October 9
15/09/2026
VIENNA and SAN FRANCISCO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- FemPulse™, a bioelectronic medical technology company with first application overactive bladder (OAB), announced today that data from two recent clinical [...]
Elevar Therapeutics Submits Marketing Authorization Application to European Medicines Agency for Lirafugratinib as a Treatment for Patients with Advanced/Metastatic Cholangiocarcinoma (CCA) Harboring FGFR2 Fusions or Rearrangements
15/09/2026
Submission initiates regulatory process in European Union following U.S. submission, expanding global market presence Lirafugratinib is a highly selective, irreversible FGFR2 inhibitor differentiated from existing pan- [...]
Correction: IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 36 - 2026
15/09/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 31 août au 4 septembre 2026 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction [...]
Correction: IPSEN - Buy-back programme - Art 5 of MAR - Week 36- 2026
15/09/2026
Aggregated presentation by day and by market Weekly report on share repurchases from 31st August to 04th September 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial [...]
Provincial funding will expand access to team-based primary care in North Western Toronto
15/09/2026
Unison Health & Community Services and Humber River Health partnership will connect more residents to ongoing, community-based care TORONTO, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Unison Health & Community Services [...]
ENvue Medical Provides Nasdaq Listing Update
15/09/2026
TYLER, Texas, Sept. 15, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (Nasdaq: FEED) (“ENvue” or the “Company”), a medical technology company focused on innovative solutions for enteral feeding and therapeutic ultrasound [...]
World’s largest vision award goes to Botond Roska and José-Alain Sahel
15/09/2026
Basel, 15 September 2026 - Botond Roska, Director of Science at the Institute of Molecular and Clinical Ophthalmology Basel (IOB), and José-Alain Sahel, University of Pittsburgh and Chair of the IOB Scientific Advisory [...]
Lobular Breast Cancer Alliance Launches Cross-Country Awareness Tour to Address Breast Cancer Visibility Gap
15/09/2026
Boston, USA, Sept. 15, 2026 (GLOBE NEWSWIRE) -- “It’s Time to Talk About Lobular Breast Cancer” campaign will travel from San Francisco to Boston, bringing urgently needed national attention to invasive lobular [...]
Egle Therapeutics to Present Clinical Data at the Upcoming European Academy of Dermatology and Venereology (EADV) Congress in Vienna
15/09/2026
Egle to share clinical data on EGL-003, the company's most advanced Treg-selective IL-2 agonist for atopic dermatitis PARIS, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Egle Therapeutics (“Egle”), a clinical-stage biotechnology [...]
Legend Biotech Appoints Ingrid Zhang as Chief Executive Officer
15/09/2026
Ingrid Zhang, an accomplished global biopharmaceutical leader, joins Legend Biotech following a comprehensive Board-led search process BRIDGEWATER, N.J., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation ( [...]
Reflect Scientific Announces Liquid Nitrogen Cooling Technology for AI Data Center Applications
15/09/2026
OREM, Utah, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), today announced that its proprietary liquid nitrogen temperature control technology is available for application in the rapidly [...]
Les Hôpitaux Shriners pour enfants Canada réalisent une première nationale en analyse du mouvement pédiatrique
15/09/2026
Seul centre d’analyse du mouvement au Canada agréé par la Commission for Motion Laboratory Accreditation (CMLA) MONTRÉAL, 15 sept. 2026 (GLOBE NEWSWIRE) -- Les Hôpitaux Shriners pour enfants Canada annoncent aujourd’hui [...]
Shriners Hospitals for Children Canada Achieves a National First in Pediatric Motion Analysis
15/09/2026
Home to Canada's only Motion Analysis Centre accredited by the Commission for Motion Laboratory Accreditation (CMLA) MONTREAL, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Shriners Hospitals for Children Canada (SHCC) today [...]
Er-Kim Announces Positive Reimbursement Decision in the Czech Republic for Vafseo® (vadadustat) to Treat Symptomatic Anaemia in Adult CKD Dialysis Patients
15/09/2026
State Institute for Drug Control (SÚKL) has officially evaluated and approved the drug’s price and coverage under the public health insurance system WARSAW, Poland, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Er-Kim , an [...]
New Data Reveal Rapid, Sustained Quality-of-Life Improvements for Eczema and Psoriasis Patients Using Zest Health's Virtual Dermatology Platform
15/09/2026
Findings published in Dermatology Practical & Conceptual show a 65.5% reduction in disease-related quality-of-life impact and a more than 4x drop in severe cases by patients' final visit WASHINGTON, Sept. 15, 2026 ( [...]
Sonus Microsystems and Medtronic Partner to Advance AI-Powered Maternal Health Monitoring
15/09/2026
Partnership will pair Medtronic vital-sign monitoring with Sonus’s ultrasound AI platform in field studies, funded by the Gates Foundation VANCOUVER, British Columbia and LAFAYETTE, Colo., Sept. 15, 2026 (GLOBE NEWSWIRE [...]
Cogent Biosciences Announces FDA Acceptance of New Drug Application (NDA) for Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM)
15/09/2026
NDA supported by positive results from the APEX pivotal trial demonstrating clinically meaningful responses and evidence of disease modification in patients with AdvSM PDUFA target action date set for June 29, 2027 [...]
Kestrel Therapeutics Receives FDA Fast Track Designation for KST-6051, a Potential Best-in-Class Pan-KRAS Inhibitor, in the treatment of KRAS-Mutant Advanced Solid Tumors
15/09/2026
WATERTOWN, Mass., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Kestrel Therapeutics Inc. (“Kestrel” or the “Company”), a clinical-stage biotechnology company developing next-generation small-molecule inhibitors targeting mutant [...]

Pages